U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2006
178
Substance Class Protein
Created
by admin
on Sat Dec 16 03:21:06 GMT 2023
Edited
by admin
on Sat Dec 16 03:21:06 GMT 2023
Protein Sub Type
Sequence Type COMPLETE
Record UNII
Z845VHQ61P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Common Name English
GARDASIL 9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN COMPONENT OF GARDASIL
Brand Name English
SILGARD COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN
Brand Name English
GARDASIL COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN
Brand Name English
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Common Name English
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE, RECOMBINANT INJECTION, SUSPENSION
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN COMPONENT OF SILGARD
Brand Name English
HUMAN PAPILLOMAVIRUS TYPE 11 CAPSID PROTEIN ANTIGEN, A
Common Name English
GARDASIL-9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Common Name English
RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN
Common Name English
HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
Common Name English
Classification Tree Code System Code
NDF-RT N0000183891
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
EMA ASSESSMENT REPORTS SILGARD (AUTHORIZED: CONDYLOMATA ACUMINATA)
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
EMA ASSESSMENT REPORTS GARDASIL (AUTHORIZED: CONDYLOMATA ACUMINATA)
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
NCI_THESAURUS C75791
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
WHO-ATC J07BM01
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
WHO-ATC J07BM03
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
Code System Code Type Description
DRUG BANK
DB10300
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
PRIMARY
EVMPD
SUB22592
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
PRIMARY
NDF-RT
N0000170916
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
PRIMARY Vaccines, Inactivated [Chemical/Ingredient]
NDF-RT
N0000183364
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
PRIMARY Actively Acquired Immunity [PE]
NDF-RT
N0000175336
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
PRIMARY Papillomavirus Vaccines [Chemical/Ingredient]
NCI_THESAURUS
C77715
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
PRIMARY
DAILYMED
Z845VHQ61P
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
PRIMARY
FDA UNII
Z845VHQ61P
Created by admin on Sat Dec 16 03:21:06 GMT 2023 , Edited by admin on Sat Dec 16 03:21:06 GMT 2023
PRIMARY
Related Record Type Details
HUMAN PAPILLOMAVIRUS SEROTYPE 11 WHOLE
TARGET ORGANISM->VACCINE ANTIGEN
Related Record Type Details
HUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966